Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 184

1.

The multifaceted role of Fas signaling in immune cell homeostasis and autoimmunity.

Siegel RM, Chan FK, Chun HJ, Lenardo MJ.

Nat Immunol. 2000 Dec;1(6):469-74. Review.

PMID:
11101867
2.

T cell receptor ligation triggers novel nonapoptotic cell death pathways that are Fas-independent or Fas-dependent.

Davidson WF, Haudenschild C, Kwon J, Williams MS.

J Immunol. 2002 Dec 1;169(11):6218-30.

5.

Expression in transgenic mice of dominant interfering Fas mutations: a model for human autoimmune lymphoproliferative syndrome.

Choi Y, Ramnath VR, Eaton AS, Chen A, Simon-Stoos KL, Kleiner DE, Erikson J, Puck JM.

Clin Immunol. 1999 Oct;93(1):34-45.

PMID:
10497009
6.

The Fas death factor.

Nagata S, Golstein P.

Science. 1995 Mar 10;267(5203):1449-56. Review.

PMID:
7533326
7.

Fas preassociation required for apoptosis signaling and dominant inhibition by pathogenic mutations.

Siegel RM, Frederiksen JK, Zacharias DA, Chan FK, Johnson M, Lynch D, Tsien RY, Lenardo MJ.

Science. 2000 Jun 30;288(5475):2354-7.

8.

The role of Fas/FasL interactions in the regulation of B cell function.

Jacobson BA, Rothstein TL, Marshak-Rothstein A.

Behring Inst Mitt. 1996 Oct;(97):185-99. Review.

PMID:
8950476
9.

Central role of defective apoptosis in autoimmunity.

Kühtreiber WM, Hayashi T, Dale EA, Faustman DL.

J Mol Endocrinol. 2003 Dec;31(3):373-99. Review.

PMID:
14664701
10.

A homozygous Fas ligand gene mutation in a patient causes a new type of autoimmune lymphoproliferative syndrome.

Del-Rey M, Ruiz-Contreras J, Bosque A, Calleja S, Gomez-Rial J, Roldan E, Morales P, Serrano A, Anel A, Paz-Artal E, Allende LM.

Blood. 2006 Aug 15;108(4):1306-12. Epub 2006 Apr 20.

11.

SPOTS: signaling protein oligomeric transduction structures are early mediators of death receptor-induced apoptosis at the plasma membrane.

Siegel RM, Muppidi JR, Sarker M, Lobito A, Jen M, Martin D, Straus SE, Lenardo MJ.

J Cell Biol. 2004 Nov 22;167(4):735-44.

12.

Apoptosis mediated by the Fas system.

Nagata S.

Prog Mol Subcell Biol. 1996;16:87-103. Review.

PMID:
8822794
13.

Negative regulation of CD95 ligand gene expression by vitamin D3 in T lymphocytes.

Cippitelli M, Fionda C, Di Bona D, Di Rosa F, Lupo A, Piccoli M, Frati L, Santoni A.

J Immunol. 2002 Feb 1;168(3):1154-66.

14.

Transgenic expression of the viral FLIP MC159 causes lpr/gld-like lymphoproliferation and autoimmunity.

Woelfel M, Bixby J, Brehm MA, Chan FK.

J Immunol. 2006 Sep 15;177(6):3814-20.

15.

Why do defects in the Fas-Fas ligand system cause autoimmunity?

Suda T, Nagata S.

J Allergy Clin Immunol. 1997 Dec;100(6 Pt 2):S97-101. Review.

PMID:
9440553
17.

Prevention of autoimmunity and control of recall response to exogenous antigen by Fas death receptor ligand expression on T cells.

Mabrouk I, Buart S, Hasmim M, Michiels C, Connault E, Opolon P, Chiocchia G, Lévi-Strauss M, Chouaib S, Karray S.

Immunity. 2008 Dec 19;29(6):922-33. doi: 10.1016/j.immuni.2008.10.007. Epub 2008 Nov 13.

18.

Fas/Fas ligand on the road: an apoptotic pathway common to AIDS, autoimmunity, lymphoproliferation and transplantation.

Famularo G, Nucera E, Marcellini S, De Simone C.

Med Hypotheses. 1999 Jul;53(1):50-62.

PMID:
10499826
19.

Fas-induced apoptosis in B cells.

Mizuno T, Zhong X, Rothstein TL.

Apoptosis. 2003 Oct;8(5):451-60. Review.

PMID:
12975576
20.

Defective apoptosis in lymphocytes and the role of IL-2 in autoimmune hematologic cytopenias.

Shenoy S, Mohanakumar T, Chatila T, Tersak J, Duffy B, Wang R, Thilenius AR, Russell JH.

Clin Immunol. 2001 May;99(2):266-75.

PMID:
11318598

Supplemental Content

Support Center